Cite
HARVARD Citation
Rey, M. et al. (2017). The reversible P2Y12 antagonist ACT‐246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat. Pharmacology research & perspectives. 5 (5), p. n/a. [Online].